1. Ioannidis JP. Biomarker failures. Clin Chem 2013;59:202–4.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000313535100033&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3
2. Rifai N, Watson ID, Miller WG. Commercial immunoassays in biomarker studies: researchers beware! Clin Chem 2012;58:1387–8.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000309383500001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3
3. Baggerly KA, Coombes KR. What information should be required to support clinical “omics” publications? Clin Chem 2011;57:688–90.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000289985100008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3
4. Favaloro EJ, Plebani M, Lippi G. Regulation of in vitro diagnostics (IVD) for use in clinical diagnostic laboratories: towards the light or dark in clinical laboratory testing. Clin Chem Lab Med 2011;49:1965–73.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000299856700006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3
5. Plebani M. Evaluating laboratory diagnostics tests and translational research. Clin Chem Lab Med 2010;48:983–8.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000279341900012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3